Nanobody-based trispecific T cell engager (Nb-TriTE) enhances therapeutic efficacy by overcoming tumor-mediated immunosuppression.
Saved in:
| Title: | Nanobody-based trispecific T cell engager (Nb-TriTE) enhances therapeutic efficacy by overcoming tumor-mediated immunosuppression. |
|---|---|
| Authors: | Ding, Ziqiang1 (AUTHOR), Sun, Shuyang1 (AUTHOR), Wang, Xuan2 (AUTHOR), Yang, Xiaomei1 (AUTHOR), Shi, Wei1 (AUTHOR), Huang, Xianing1 (AUTHOR), Xie, Shenxia1 (AUTHOR), Mo, Fengzhen1 (AUTHOR), Hou, Xiaoqiong1 (AUTHOR), Liu, Aiqun1 (AUTHOR), Jiang, Xiaobing2 (AUTHOR), Tang, Zhuoran1 (AUTHOR) soup1990@126.com, Lu, Xiaoling1 (AUTHOR) luxiaoling@gxmu.edu.cn |
| Source: | Journal of Hematology & Oncology. 11/29/2023, Vol. 16 Issue 1, p1-20. 20p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
